Multiple inflammatory signaling proteins

Multiple inflammatory signaling proteins represent a broad class of molecular mediators, including cytokines, chemokines, and intracellular signaling molecules, that orchestrate the body's immune response to stimuli (Source: StatPearls, 2023). This group includes well-characterized targets such as Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), which act as primary drivers of systemic and local inflammation (Source: Nature Reviews Immunology, 2018). Intracellularly, these signals are often propagated through pathways such as the Janus kinase-signal transducer and activator of transcription (JAK-STAT) and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) systems (Source: PubMed, 2021). Chronic overactivation of these signaling proteins is fundamentally linked to the pathogenesis of autoimmune diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease (Source: NIH, 2022). Therapeutic strategies targeting these proteins include monoclonal antibodies like adalimumab and tocilizumab, as well as small molecule inhibitors like tofacitinib (Source: PubChem, 2024). Because the term refers to a heterogeneous collection of proteins rather than a single specific receptor or enzyme, it is considered a functional category rather than a discrete therapeutic target. Monitoring efficacy in therapies targeting these proteins often involves measuring systemic biomarkers such as C-reactive protein (CRP) or specific cytokine levels (Source: Mayo Clinic, 2023). Safety concerns associated with modulating these pathways primarily involve an increased risk of opportunistic infections and potential immunosuppression due to the inhibition of normal host defense mechanisms (Source: FDA, 2022).

Other names

Inflammatory mediatorsPro-inflammatory cytokinesInflammatory signaling moleculesInflammatory cascade proteins

Neutralization of pro-inflammatory cytokines or inhibition of intracellular signaling pathways such as JAK-STAT, NF-kappaB, and MAPK cascades.